WO2005095461A3 - Gold-binding protein and use thereof - Google Patents

Gold-binding protein and use thereof Download PDF

Info

Publication number
WO2005095461A3
WO2005095461A3 PCT/JP2005/006815 JP2005006815W WO2005095461A3 WO 2005095461 A3 WO2005095461 A3 WO 2005095461A3 JP 2005006815 W JP2005006815 W JP 2005006815W WO 2005095461 A3 WO2005095461 A3 WO 2005095461A3
Authority
WO
WIPO (PCT)
Prior art keywords
gold
protein
binding protein
antibody
binding
Prior art date
Application number
PCT/JP2005/006815
Other languages
French (fr)
Other versions
WO2005095461A2 (en
Inventor
Hidenori Shiotsuka
Takeshi Imamura
Izumi Kumagai
Original Assignee
Canon Kk
Hidenori Shiotsuka
Takeshi Imamura
Izumi Kumagai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canon Kk, Hidenori Shiotsuka, Takeshi Imamura, Izumi Kumagai filed Critical Canon Kk
Priority to CN2005800105197A priority Critical patent/CN1946741B/en
Priority to US10/592,791 priority patent/US7833731B2/en
Priority to EP05728901A priority patent/EP1732952A2/en
Publication of WO2005095461A2 publication Critical patent/WO2005095461A2/en
Publication of WO2005095461A3 publication Critical patent/WO2005095461A3/en
Priority to US12/473,199 priority patent/US7871614B2/en
Priority to US12/473,203 priority patent/US7807391B2/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/60Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622Single chain antibody (scFv)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/90Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Abstract

A protein utilizing an anti-gold antibody and a gold-binding side which is a part of the anti-gold antibody is constructed. This protein is capable of specifically binding to gold. This protein or a complex protein containing such a protein can be used for the detection of a target substance.
PCT/JP2005/006815 2004-03-31 2005-03-31 Gold-binding protein and use thereof WO2005095461A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CN2005800105197A CN1946741B (en) 2004-03-31 2005-03-31 Gold-binding protein and its use
US10/592,791 US7833731B2 (en) 2004-03-31 2005-03-31 Gold-binding protein and use thereof
EP05728901A EP1732952A2 (en) 2004-03-31 2005-03-31 Gold-binding protein and use thereof
US12/473,199 US7871614B2 (en) 2004-03-31 2009-05-27 Gold-binding protein and use thereof
US12/473,203 US7807391B2 (en) 2004-03-31 2009-05-27 Gold-binding protein and use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004108388 2004-03-31
JP2004-108388 2004-03-31

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US10/592,791 A-371-Of-International US7833731B2 (en) 2004-03-31 2005-03-31 Gold-binding protein and use thereof
US12/473,199 Division US7871614B2 (en) 2004-03-31 2009-05-27 Gold-binding protein and use thereof
US12/473,203 Division US7807391B2 (en) 2004-03-31 2009-05-27 Gold-binding protein and use thereof

Publications (2)

Publication Number Publication Date
WO2005095461A2 WO2005095461A2 (en) 2005-10-13
WO2005095461A3 true WO2005095461A3 (en) 2006-12-14

Family

ID=35064450

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2005/006815 WO2005095461A2 (en) 2004-03-31 2005-03-31 Gold-binding protein and use thereof

Country Status (6)

Country Link
US (3) US7833731B2 (en)
EP (3) EP1732952A2 (en)
JP (1) JP4208942B2 (en)
KR (3) KR100924044B1 (en)
CN (3) CN1946741B (en)
WO (1) WO2005095461A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4838626B2 (en) 2005-04-28 2011-12-14 キヤノン株式会社 Substrate for target substance detection element used in apparatus for detecting target substance using plasmon resonance, detection element and detection apparatus using the same
WO2006129843A2 (en) 2005-05-31 2006-12-07 Canon Kabushiki Kaisha Bispecific capturing molecule
US7875465B2 (en) 2005-05-31 2011-01-25 Canon Kabushiki Kaisha Target substance capturing molecule
JP2006333825A (en) * 2005-06-03 2006-12-14 Canon Inc Method for producing protein for catching target substance and method for selecting constituting material of the same
CA2609023C (en) * 2005-08-01 2012-11-27 Canon Kabushiki Kaisha Target substance detecting device, target substance detecting method using the same, and detecting apparatus and kit therefor
US20090130776A1 (en) * 2005-09-01 2009-05-21 Canon Kabushiki Kaisha Binding protein molecule
WO2007072986A1 (en) * 2005-12-22 2007-06-28 Canon Kabushiki Kaisha Substrate for target substance detecting device, target substance detecting device, target substance detecting apparatus and method using the same, and kit therefor
WO2007114512A1 (en) * 2006-03-31 2007-10-11 Canon Kabushiki Kaisha Method for detecting target substance and target-substance detection kit
JP2007278748A (en) * 2006-04-04 2007-10-25 Canon Inc Target substance detecting element, detection material, and detection kit
US7811829B2 (en) 2006-06-08 2010-10-12 Canon Kabushiki Kaisha Measuring probe and production process thereof
JP5247106B2 (en) * 2006-10-13 2013-07-24 キヤノン株式会社 Protein, protein immobilization method, structure, biosensor, nucleic acid, vector, and target substance detection kit
JP5300205B2 (en) * 2007-03-22 2013-09-25 キヤノン株式会社 Target substance detection element, target substance detection method, and method for manufacturing target substance detection element
CN101970485B (en) * 2007-09-26 2014-05-14 U3制药有限公司 Heparin-binding epidermal growth factor-like growth factor antigen binding proteins
JP5172638B2 (en) * 2008-12-16 2013-03-27 日本電信電話株式会社 Method for evaluating the orientation of membrane proteins in lipid membranes
PT2491056T (en) * 2009-10-22 2021-10-26 Univ Of Twente Vhh for application in tissue repair, organ regeneration, organ replacement and tissue engineering
EP2804952A4 (en) * 2012-01-19 2015-09-09 Therapeutic Proteins Int Llc Stabilization of the anti-cd20 antibody rituximab
CN103675052B (en) * 2013-12-25 2015-11-11 华中师范大学 A kind of electrochemical immunosensor detecting dibutyl phthalate and its preparation method and application
US11874268B2 (en) * 2016-06-12 2024-01-16 Nanohesgarsazan Salamat Arya Ncubation Center For Equipment And Devices Method and system for metastasis diagnosis and prognosis
JP7304028B2 (en) 2018-11-07 2023-07-06 Dic株式会社 Antigen Recognition Receptor, Antigen Measurement Kit, and Antigen Detection Method
JP7315163B2 (en) * 2019-03-22 2023-07-26 学校法人早稲田大学 OPTICAL DEVICE, ANALYZER, AND OPTICAL DEVICE MANUFACTURING METHOD

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235457A2 (en) * 1985-12-13 1987-09-09 Syngene International N.V. Monoclonal antibodies
US4769223A (en) * 1987-04-22 1988-09-06 Bohumil Volesky Biosorbent for gold
JPH0555534A (en) * 1991-08-22 1993-03-05 Seiko Instr Inc Production of laminated semiconductor device
WO1995000845A1 (en) * 1993-06-22 1995-01-05 Bionebraska, Inc. Mca assay/kit for detecting metal cations
US5503987A (en) * 1989-03-14 1996-04-02 Board Of Regents Of The University Of Nebraska Monoclonal antibodies specific for small moieties and method for their use
WO1999045110A1 (en) * 1998-03-06 1999-09-10 Diatech Pty. Ltd. V-like domain binding molecules
WO2002002641A1 (en) * 2000-06-16 2002-01-10 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to blys
US20030049800A1 (en) * 2000-12-15 2003-03-13 Saravis Calvin A. Compositions and methods for producing antibodies to low molecular weight analytes
WO2003055979A2 (en) * 2001-11-16 2003-07-10 Human Genome Sciences, Inc. ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO BLyS

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3086182B2 (en) * 1995-12-19 2000-09-11 ライト工業株式会社 Soil purification method
US4732864A (en) 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
US5639624A (en) * 1989-03-14 1997-06-17 Board Of Regents Of The University Of Nebraska Monoclonal antibodies specific for metallic cations and method therefor
JP3108115B2 (en) 1991-03-28 2000-11-13 ロート製薬株式会社 Substance detection method by immunochromatography
CA2122732C (en) * 1991-11-25 2008-04-08 Marc D. Whitlow Multivalent antigen-binding proteins
US6096530A (en) * 1992-04-22 2000-08-01 Canon Kabushiki Kaisha Pseudomonas cepacia strain isolated from termite intestines that degrades trichlorethylene and furan compounds
JP3406926B2 (en) * 1993-02-18 2003-05-19 キヤノン株式会社 Method for biodegrading trichlorethylene and method for biodegrading organic chlorine compounds using microorganisms
US5837242A (en) * 1992-12-04 1998-11-17 Medical Research Council Multivalent and multispecific binding proteins, their manufacture and use
US5639627A (en) * 1993-02-04 1997-06-17 Sumitomo Pharmaceuticals Co., Ltd. Method for assaying specific antibody
EP0646642A3 (en) * 1993-09-30 1995-08-16 Canon Kk Microorganism-holding carrier and method for remediation of soil employing the carrier.
EP0659450B1 (en) * 1993-12-22 1999-10-20 Canon Kabushiki Kaisha Process for decomposing a chloroorganic compound and for remedying environment with microorganisms
US5476939A (en) * 1993-12-30 1995-12-19 Abbott Laboratories Certain pyridyl and isoquinolyl carbinolamine derivatives
DE69514871T2 (en) * 1994-05-30 2000-06-29 Canon Kk Corynebacterium sp. J1, Process for biodegrading aromatic compounds and / or chlorinated organic compounds, and process for detoxifying the environment therewith
DE69516637T2 (en) * 1994-11-21 2000-09-21 Canon Kk Process for the degradation of pollutants and environmental remediation using microorganisms and the microorganism used
JP3478619B2 (en) * 1994-12-02 2003-12-15 キヤノン株式会社 Novel microorganism KB2 and biodegradation treatment method of aromatic compound and / or volatile organochlorine compound using the same
JP3108006B2 (en) * 1995-02-28 2000-11-13 キヤノン株式会社 JM1 strain, environmental restoration method, organic compound decomposition method, microorganism acquisition method, microorganism detection method, and microorganism detection kit
JP3083077B2 (en) * 1996-04-11 2000-09-04 キヤノン株式会社 Organic compound biodegradation method and environmental restoration method
JP3347596B2 (en) * 1996-08-01 2002-11-20 キヤノン株式会社 A novel microorganism, a method for biodegrading aromatic compounds and / or organic chlorine compounds, and a method for purifying a medium
JP3323746B2 (en) * 1996-08-01 2002-09-09 キヤノン株式会社 Novel microorganisms, organic compound biodegradation method and environmental restoration method
CA2229754C (en) * 1997-02-18 2002-04-09 Canon Kabushiki Kaisha Method for culturing microorganism, method for biosynthesizing organic compound, method for maintaining microbial ability to decompose polluting substance, method for decomposing pollutant, and method for remedying environment
CN1163399A (en) * 1997-04-16 1997-10-29 郭兴华 Biological auti-fake technology
JP3673640B2 (en) * 1997-05-15 2005-07-20 キヤノン株式会社 Method for purifying contaminated medium and purification device used therefor
US6551495B1 (en) * 1997-11-21 2003-04-22 Inverness Medical Switzerland Gmbh Electrochemical assays
US6864074B2 (en) * 1998-10-30 2005-03-08 Canon Kabushiki Kaisha Dna fragment carrying toluene monooxygenase gene, recombinant plasmid, transformed microorganism, method for degrading chlorinated aliphatic hydrocarbon compounds and aromatic compounds, and method for environmental remediation
US6472191B1 (en) * 1998-12-03 2002-10-29 Canon Kabushiki Kaisha Dna fragment carrying toluene monooxygenase gene, recombinant plasmid, transformed microorganism, method for degrading chlorinated aliphatic hydrocarbon compounds and aromatic compounds, and method for environmental remediation
JP3684150B2 (en) * 1999-12-27 2005-08-17 キヤノン株式会社 Polyhydroxyalkanoate
US6861550B2 (en) * 2000-02-29 2005-03-01 Canon Kabushiki Kaisha Polyhydroxyalkanoate containing 3-hydroxybenzoylalkanoic acid as monomer unit, and method for producing the same
US6479621B2 (en) * 2000-02-29 2002-11-12 Canon Kabushiki Kaisha Polyhydroxyalkanoate containing 3-hydroxythienylalkanoic acid as monomer unit and method for producing the same
US7220840B2 (en) * 2000-06-16 2007-05-22 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to B lymphocyte stimulator protein
JP3768799B2 (en) * 2000-10-30 2006-04-19 キヤノン株式会社 Process for producing polyhydroxyalkanoate from substituted fatty acid ester
JP3720779B2 (en) * 2001-02-28 2005-11-30 キヤノン株式会社 NOVEL POLYHYDROXYALKANOATE TYPE POLYESTER HAVING VINYLPHENYL STRUCTURE IN SIDE CHAIN AND PROCESS FOR PRODUCING THE SAME
JP3748537B2 (en) * 2001-03-01 2006-02-22 キヤノン株式会社 POLYHYDROXYALKANOATE AND PROCESS FOR PRODUCING THE SAME, AND ω- (2-THIENYLSULFANYL) ALKANOIC ACID AND PROCESS FOR PRODUCING THE SAME
KR100487555B1 (en) * 2001-04-27 2005-05-06 캐논 가부시끼가이샤 Novel polyhydroxyalkanoate, producing method therefor, charge control agent containing such polyhydroxyalkanoate, toner contatining such charge control agent and image-forming method and image-forming apparatus utilizing such toner
KR100528749B1 (en) * 2001-04-27 2005-11-15 캐논 가부시끼가이샤 Novel polyhydroxyalkanoates having in its side chain phenylsulfinyl structure and/or phenyl sulfonyl structure and production process therefor, charge control agent, toner binder and toner containing same, and image forming method and image forming apparatus using the toner
JP3496002B2 (en) * 2001-04-27 2004-02-09 キヤノン株式会社 Binder resin containing novel polyhydroxyalkanoate, toner containing the binder resin; image forming method and image forming apparatus using the toner
KR100461511B1 (en) * 2001-04-27 2004-12-14 캐논 가부시끼가이샤 Novel polyhydroxyalkanoate, its production method, charge control agent containing the polyhydroxyalkanoate, toner binder and toner, and image forming method image forming apparatus using the toner
JP3501771B2 (en) * 2001-04-27 2004-03-02 キヤノン株式会社 Binder resin containing polyhydroxyalkanoate, toner containing the binder resin; image forming method and image forming apparatus using the toner
US6869782B2 (en) * 2001-07-10 2005-03-22 Canon Kabushiki Kaisha Polyhydroxyalkanoate that comprises unit having (methylsulfanyl) phenoxy structure in side chain thereof and process for producing the same
US20030073104A1 (en) 2001-10-02 2003-04-17 Belcher Angela M. Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
CN1140802C (en) * 2001-10-25 2004-03-03 中国科学院武汉病毒研究所 Microbe detection method for surveying gold mine
JP4078247B2 (en) * 2003-05-02 2008-04-23 キヤノン株式会社 Magnetic substance-biological substance complex type structure, peptide fragment having amino acid sequence capable of binding to magnetic substance and gene thereof, and method for producing magnetic substance-biological substance complex type structure
US7701138B2 (en) * 2003-07-02 2010-04-20 Canon Kabushiki Kaisha Information acquisition method, information acquisition apparatus and disease diagnosis method
JP2005204609A (en) * 2004-01-26 2005-08-04 Canon Inc Kit for immobilizing organic material, structure in which organic material is immobilized and method for producing the same structure
US7504086B2 (en) * 2004-03-31 2009-03-17 Canon Kabushiki Kaisha Structure and method for releasing substance therefrom
JP2006333825A (en) * 2005-06-03 2006-12-14 Canon Inc Method for producing protein for catching target substance and method for selecting constituting material of the same
JP2007278748A (en) * 2006-04-04 2007-10-25 Canon Inc Target substance detecting element, detection material, and detection kit
US7811829B2 (en) * 2006-06-08 2010-10-12 Canon Kabushiki Kaisha Measuring probe and production process thereof

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235457A2 (en) * 1985-12-13 1987-09-09 Syngene International N.V. Monoclonal antibodies
US4769223A (en) * 1987-04-22 1988-09-06 Bohumil Volesky Biosorbent for gold
US5503987A (en) * 1989-03-14 1996-04-02 Board Of Regents Of The University Of Nebraska Monoclonal antibodies specific for small moieties and method for their use
JPH0555534A (en) * 1991-08-22 1993-03-05 Seiko Instr Inc Production of laminated semiconductor device
WO1995000845A1 (en) * 1993-06-22 1995-01-05 Bionebraska, Inc. Mca assay/kit for detecting metal cations
WO1999045110A1 (en) * 1998-03-06 1999-09-10 Diatech Pty. Ltd. V-like domain binding molecules
WO2002002641A1 (en) * 2000-06-16 2002-01-10 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to blys
US20030049800A1 (en) * 2000-12-15 2003-03-13 Saravis Calvin A. Compositions and methods for producing antibodies to low molecular weight analytes
WO2003055979A2 (en) * 2001-11-16 2003-07-10 Human Genome Sciences, Inc. ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO BLyS

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BARBAS III C F ET AL: "MOLECULAR PROFILE OF AN ANTIBODY RESPONSE TO HIV-1 AS PROBED BY COMBINATORIAL LIBRARIES", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 230, no. 3, 5 April 1993 (1993-04-05), pages 812 - 823, XP000942828, ISSN: 0022-2836 *
BROWN S: "Metal-recognition by repeating polypeptides", NATURE BIOTECHNOLOGY, NATURE PUBLISHING, US, vol. 15, no. 3, 1997, pages 269 - 272, XP002240664, ISSN: 1087-0156 *
LEE SEUNG-WUK ET AL: "Ordering of quantum dots using genetically engineered viruses.", SCIENCE. 3 MAY 2002, vol. 296, no. 5569, 3 May 2002 (2002-05-03), pages 892 - 895, XP002363586, ISSN: 1095-9203 *
PATENT ABSTRACTS OF JAPAN vol. 017, no. 356 (E - 1394) 6 July 1993 (1993-07-06) *

Also Published As

Publication number Publication date
WO2005095461A2 (en) 2005-10-13
US7871614B2 (en) 2011-01-18
EP2267034A3 (en) 2011-06-22
KR100924044B1 (en) 2009-10-27
US7833731B2 (en) 2010-11-16
EP1732952A2 (en) 2006-12-20
KR100940138B1 (en) 2010-02-03
KR20080006022A (en) 2008-01-15
EP2267034A2 (en) 2010-12-29
CN101921338A (en) 2010-12-22
KR100923828B1 (en) 2009-10-27
EP2267033A2 (en) 2010-12-29
CN101921340A (en) 2010-12-22
US20070178522A1 (en) 2007-08-02
US20090281284A1 (en) 2009-11-12
EP2267033A3 (en) 2011-03-30
US7807391B2 (en) 2010-10-05
KR20080006021A (en) 2008-01-15
CN1946741A (en) 2007-04-11
US20090311806A1 (en) 2009-12-17
KR20070010041A (en) 2007-01-19
JP2008167756A (en) 2008-07-24
JP4208942B2 (en) 2009-01-14
CN1946741B (en) 2012-09-05

Similar Documents

Publication Publication Date Title
WO2005095461A3 (en) Gold-binding protein and use thereof
WO2005047860A3 (en) Antibodies to alpha-synuclein
WO2007086997A3 (en) Sensors
WO2005085869A3 (en) Determination of analyte characteristics based upon binding properties
WO2007008864A3 (en) Wireless cmos biosensor
WO2006124641A3 (en) Anti-mesothelin antibodies useful for immunological assays
WO2006085897A3 (en) Microfluidic device and leucocyte antigen mediated microfluidic assay
WO2008070865A3 (en) Materials and methods for efficient and accurate detection of analytes
WO2005118836A3 (en) Hif prolyl hydroxylase activity assay
WO2006073738A3 (en) Colorimetric sensors constructed of diacetylene materials
WO2006086561A3 (en) Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus
IL200608A0 (en) Methods for the detection of 193p1e1b protein and use of compositions containing a 193p1e1b protein or an antibody binding thereto
EP1956372A4 (en) Ultrahighly sensitive determination reagent for c-reactive protein and determination method
WO2006084264A3 (en) Cd20 antibody variants and uses thereof
IL178593A0 (en) Fc??riib-specific antibodies and methods of use thereof
WO2008121742A3 (en) Inhibitors of bruton's tyrosine kinase
AU2013207599A1 (en) Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof
WO2007068485A3 (en) Biological materials and uses thereof
WO2005120166A3 (en) Antibodies for selective apoptosis of cells
AU2006239318A8 (en) Cancer specific PCNA isoform binding antibodies and uses thereof
WO2004111081A3 (en) Antigenic peptides of sars coronavirus and uses thereof
IL202598A0 (en) High sensitivity immunoassays and kits for the determination of peptides and proteins of biological interest
EP1915176A4 (en) Highly sensitive immunoassays and antibodies for detection of blood factor viii
WO2006091421A3 (en) Peptides for detection of antibody to ehrlichia ewingii
WO2006076687A3 (en) Elisa assays using prion-specific peptide reagents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 10592791

Country of ref document: US

Ref document number: 2007178522

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2005728901

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 200580010519.7

Country of ref document: CN

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 1020067022797

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2005728901

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020067022797

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 10592791

Country of ref document: US